We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Harnessing AI in a Battle Against Aging
Blog

A recently announced collaboration between Juvenescence, Ltd., and NetraMark Corp. has yielded a new joint venture, NetraPharma, which aims to fight aging-related conditions. We spoke with NetraMark founder Dr. Joseph Geraci to find out more about how the process of targeting and treating neurodegenerative disorders will be radically changed by AI.

Read More

Can We Treat Mood Disorders with Pharmacological Therapeutics?
Blog

Clinical treatments for neurological and mood disorders like social anxiety disorder and major depressive disorder have failed to show consistent efficacy in treating patients. VistaGen Therapeutics is aiming to correct that. We talked to VistaGen’s CEO, Shawn Singh, about the need for treatments in this area and why Vistagen thinks their compounds AV-101 and PH94B could be promising therapies.

Read More

Brain Injury Diagnosed With Single Drop of Blood: a Follow-up
Blog

What do biomarkers and a 1990s TGIF party have in common? Find out here...
TBIcheck is a rapid point-of-care diagnostic device that detects biomarkers indicative of mild traumatic brain injury. To find out more, we spoke with the head of the Biomedical Proteomics Group, Jean-Charles Sanchez.

Read More

Combating Neurodegenerative and Age-related Diseases
Blog

We recently spoke to Karoly Nikolich, chairman and chief executive officer of Alkahest, a clinical-stage biotechnology company, to learn more about their approach to developing therapeutics for both neurodegenerative and age-related diseases.

Read More

How to Buy Neuroscience Equipment
Blog

Lab equipment purchases, both big and small, require plenty of thought and can have a big impact on the quality of your science. In this blog, MCI Neuroscience's Adam Tozer highlights some tips to making the best purchases.

Read More

Candidate Drug Proposes a Botanical Solution to Neuropathic Pain
Blog

NeuroBo Pharmaceuticals’ first lead candidate, NB-01, is positioned as a potential treatment for diabetic neuropathic pain. The candidate, which in 2018 will move into a phase III clinical trial, uses extracts of two species of the plant genus Dioscorea, used in traditional medicine for centuries, but never yet subject to systematic study. We caught up with NeuroBo’s Mark Versavel and Nandan Padukone to find out more.

Read More

Electrophysiology Goes Digital
Blog

Dr Jan Dolzer, a scientist-turned-engineer that has spent his career at the leading edge of amplifier development, describes the capability of Sutter's all new digital patch clamp system

Read More

Sustainability Through Innovation
Blog

With growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.

Read More

Developing Neuroprotective Therapies: Defending the Nervous System from Damage
Blog

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners recently announced the launch of Magnolia Neurosciences Corporation – a biopharmaceutical company advancing a new class of neuroprotective medicines.

Read More

From Growing Cells to Growing a Business
Blog

How do you start, grow and run a successful life science company? To find out we spoke to Dr Yichen Shi, CEO of Axol Bioscience.

Read More